Irbesartan and Hydrochlorothiazide - IRBESARTAN AND HYDROCHLOROTHIAZIDE
Navigation: NDC > Supplier starting with: W > WATSON LABORATORIES, INC.| Field | Value |
|---|---|
| NDC Code: | 0591-2785 |
| Proprietary Name: | Irbesartan and Hydrochlorothiazide |
| Suffix: | |
| Non-Proprietary Name: | IRBESARTAN AND HYDROCHLOROTHIAZIDE |
| Dosage Form: | TABLET, FILM COATED |
| Method: | ORAL |
| Original Marketing Date: | 22-10-2012 |
| Category Name: | ANDA |
| Application Number: | ANDA091539 |
| Labeler: | WATSON LABORATORIES, INC. |
| Substance Name: | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| Active Numerator Strength: | 12.5; 150 |
| Active Ingredient Unit: | mg/1; mg/1 |
| Pharm Classes: | Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |